Centro De Patologia Avanzada De Puerto Rico - , 00959

Centro De Patologia Avanzada De Puerto Rico entered the industry of Pathological Laboratories in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621511, which describes it as a Pathological Laboratories. For further clarification, the SIC classifies this business under the code 8071 and described it as a Pathological Laboratories. The business provides service to the B2C market.

To acquire more information, please contact Delba Garrastegui by calling (787) 995-1818 during business hours. You can also write to the business’ Single Location at Calle 8 Bloque I 32 Dvlas St Cal, , 00959. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Centro De Patologia Avanzada De Puerto Rico
Representative: Delba Garrastegui
Place of Business: Calle 8 Bloque I 32 Dvlas St Cal, , 00959
Contact Number: (787) 995-1818
Type of Service: Pathological Laboratories
SIC Number: 8071
NAICS Number: 621511
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2002
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Centro De Patologia Avanzada De Puerto Rico is a company operating from , providing professional Pathological Laboratories and relevant B2C variables. It was founded in 2002 and registered with the SIC code 8071 as Pathological Laboratories, and with the NAICS code 621511 as Pathological Laboratories.

With a current employee count of 1 to 4, Centro De Patologia Avanzada De Puerto Rico has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Delba Garrastegui at (787) 995-1818 for related queries, or to locate its Single Location using the coordinates 18.39273,-66.14385.

The Single Location can also be found at the street address Calle 8 Bloque I 32 Dvlas St Cal in , 00959 and can be engaged online through the company website at , the company Twitter , and Facebook page .